Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_C2,13 | Lung | Primary cancer | 3,017 | Tumor/Malignant | 59.2% | 0.95 | 0.16 |
| NSCLC_38242124__IMC__178_C2,14 | Lung | Primary cancer | 648 | Stromal | 50.2% | 1.00 | 0.05 |
| NSCLC_38242124__IMC__178_C2,15 | Lung | Primary cancer | 513 | Stromal | 39.4% | 0.40 | 0.95 |
| NSCLC_38242124__IMC__178_C2,16 | Lung | Primary cancer | 1,161 | Tumor/Malignant | 35.0% | 0.58 | 0.74 |
| NSCLC_38242124__IMC__178_C2,17 | Lung | Primary cancer | 4,878 | Immune | 72.8% | 0.91 | 0.23 |
| NSCLC_38242124__IMC__178_C2,3 | Lung | Primary cancer | 1,462 | Tumor/Malignant | 58.6% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__178_C2,4 | Lung | Primary cancer | 2,930 | Tumor/Malignant | 59.6% | 0.94 | 0.22 |
| NSCLC_38242124__IMC__178_C2,5 | Lung | Primary cancer | 2,052 | Stromal | 39.5% | 0.86 | 0.37 |
| NSCLC_38242124__IMC__178_C2,7 | Lung | Primary cancer | 2,504 | Other | 30.2% | 0.56 | 0.78 |
| NSCLC_38242124__IMC__178_C2,8 | Lung | Primary cancer | 1,063 | Stromal | 51.6% | 0.91 | 0.26 |
| NSCLC_38242124__IMC__178_C2,9 | Lung | Primary cancer | 1,691 | Other | 27.7% | 0.40 | 0.89 |
| NSCLC_38242124__IMC__178_C3,1 | Lung | Primary cancer | 491 | Tumor/Malignant | 31.2% | 0.52 | 0.95 |
| NSCLC_38242124__IMC__178_C3,10 | Lung | Primary cancer | 3,872 | Tumor/Malignant | 31.2% | 0.54 | 0.64 |
| NSCLC_38242124__IMC__178_C3,12 | Lung | Primary cancer | 1,491 | Stromal | 31.4% | 0.79 | 0.51 |
| NSCLC_38242124__IMC__178_C3,13 | Lung | Primary cancer | 1,139 | Stromal | 36.4% | 0.82 | 0.47 |
| NSCLC_38242124__IMC__178_C3,14 | Lung | Primary cancer | 1,703 | Stromal | 89.3% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__178_C3,17 | Lung | Primary cancer | 5,795 | Immune | 87.9% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__178_C3,18 | Lung | Primary cancer | 4,246 | Tumor/Malignant | 84.4% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__178_C3,2 | Lung | Primary cancer | 403 | Tumor/Malignant | 51.9% | 0.88 | 0.34 |
| NSCLC_38242124__IMC__178_C3,4 | Lung | Primary cancer | 4,062 | Stromal | 34.5% | 0.76 | 0.47 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_C2,13 | Lung | Primary cancer | 3,017 | Tumor/Malignant | 54.3% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__178_C2,14 | Lung | Primary cancer | 648 | Stromal | 59.0% | 0.98 | 0.11 |
| NSCLC_38242124__IMC__178_C2,15 | Lung | Primary cancer | 513 | Other | 41.5% | 0.61 | 0.67 |
| NSCLC_38242124__IMC__178_C2,16 | Lung | Primary cancer | 1,161 | Other | 26.9% | 0.50 | 0.82 |
| NSCLC_38242124__IMC__178_C2,17 | Lung | Primary cancer | 4,878 | Lymphoid | 71.9% | 0.91 | 0.25 |
| NSCLC_38242124__IMC__178_C2,3 | Lung | Primary cancer | 1,462 | Tumor/Malignant | 30.0% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__178_C2,4 | Lung | Primary cancer | 2,930 | Tumor/Malignant | 51.4% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__178_C2,5 | Lung | Primary cancer | 2,052 | Stromal | 34.1% | 0.89 | 0.33 |
| NSCLC_38242124__IMC__178_C2,7 | Lung | Primary cancer | 2,504 | Other | 23.3% | 0.34 | 0.98 |
| NSCLC_38242124__IMC__178_C2,8 | Lung | Primary cancer | 1,063 | Stromal | 45.2% | 0.72 | 0.53 |
| NSCLC_38242124__IMC__178_C2,9 | Lung | Primary cancer | 1,691 | Stromal | 29.5% | 0.73 | 0.65 |
| NSCLC_38242124__IMC__178_C3,1 | Lung | Primary cancer | 491 | Tumor/Malignant | 38.5% | 0.47 | 0.99 |
| NSCLC_38242124__IMC__178_C3,10 | Lung | Primary cancer | 3,872 | Tumor/Malignant | 32.3% | 0.53 | 0.65 |
| NSCLC_38242124__IMC__178_C3,12 | Lung | Primary cancer | 1,491 | Stromal | 28.3% | 0.82 | 0.49 |
| NSCLC_38242124__IMC__178_C3,13 | Lung | Primary cancer | 1,139 | Stromal | 31.9% | 0.84 | 0.44 |
| NSCLC_38242124__IMC__178_C3,14 | Lung | Primary cancer | 1,703 | Stromal | 89.4% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__178_C3,17 | Lung | Primary cancer | 5,795 | Lymphoid | 84.1% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__178_C3,18 | Lung | Primary cancer | 4,246 | Tumor/Malignant | 84.4% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__178_C3,2 | Lung | Primary cancer | 403 | Tumor/Malignant | 56.1% | 0.83 | 0.35 |
| NSCLC_38242124__IMC__178_C3,4 | Lung | Primary cancer | 4,062 | Stromal | 31.6% | 0.42 | 0.90 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_C2,13 | Lung | Primary cancer | 3,017 | Tumor/Malignant cell | 58.8% | 0.95 | 0.16 |
| NSCLC_38242124__IMC__178_C2,14 | Lung | Primary cancer | 648 | Fibroblast | 64.7% | 0.66 | 0.56 |
| NSCLC_38242124__IMC__178_C2,15 | Lung | Primary cancer | 513 | Other | 41.5% | 0.61 | 0.67 |
| NSCLC_38242124__IMC__178_C2,16 | Lung | Primary cancer | 1,161 | Tumor/Malignant cell | 34.9% | 0.58 | 0.75 |
| NSCLC_38242124__IMC__178_C2,17 | Lung | Primary cancer | 4,878 | B cell | 37.0% | 0.88 | 0.34 |
| NSCLC_38242124__IMC__178_C2,3 | Lung | Primary cancer | 1,462 | Tumor/Malignant cell | 58.4% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__178_C2,4 | Lung | Primary cancer | 2,930 | Tumor/Malignant cell | 60.4% | 0.94 | 0.24 |
| NSCLC_38242124__IMC__178_C2,5 | Lung | Primary cancer | 2,052 | Fibroblast | 24.8% | 0.46 | 1.00 |
| NSCLC_38242124__IMC__178_C2,7 | Lung | Primary cancer | 2,504 | Other | 26.8% | 0.58 | 0.80 |
| NSCLC_38242124__IMC__178_C2,8 | Lung | Primary cancer | 1,063 | Fibroblast | 35.4% | 0.88 | 0.37 |
| NSCLC_38242124__IMC__178_C2,9 | Lung | Primary cancer | 1,691 | Other | 26.1% | 0.42 | 0.97 |
| NSCLC_38242124__IMC__178_C3,1 | Lung | Primary cancer | 491 | Fibroblast | 32.2% | 0.50 | 0.98 |
| NSCLC_38242124__IMC__178_C3,10 | Lung | Primary cancer | 3,872 | Tumor/Malignant cell | 39.4% | 0.79 | 0.47 |
| NSCLC_38242124__IMC__178_C3,12 | Lung | Primary cancer | 1,491 | Fibroblast | 30.6% | 0.79 | 0.52 |
| NSCLC_38242124__IMC__178_C3,13 | Lung | Primary cancer | 1,139 | Fibroblast | 33.4% | 0.81 | 0.50 |
| NSCLC_38242124__IMC__178_C3,14 | Lung | Primary cancer | 1,703 | Fibroblast | 90.3% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__178_C3,17 | Lung | Primary cancer | 5,795 | B cell | 70.4% | 0.95 | 0.15 |
| NSCLC_38242124__IMC__178_C3,18 | Lung | Primary cancer | 4,246 | Tumor/Malignant cell | 84.4% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__178_C3,2 | Lung | Primary cancer | 403 | Tumor/Malignant cell | 56.1% | 0.83 | 0.35 |
| NSCLC_38242124__IMC__178_C3,4 | Lung | Primary cancer | 4,062 | Fibroblast | 26.9% | 0.46 | 0.97 |